Dr. Jennifer L. Frampton, DO

Dr. Frampton practices at Yale Medicine in New Haven, Connecticut.

Dr. Frampton's NPI, 1114347309, was assigned on April 26, 2014. Dr. Frampton graduated from Lake Erie College of Osteopathic Medicine, Erie in 2014. Dr. Frampton holds Connecticut license 69115.

Dr. Frampton's primary practice is Yale Medicine, at 50 Division St, New Haven, CT 06511 in South Central Ct County. The practice phone is (203) 785-2140.

Dr. Frampton's primary practice is Yale Medicine in New Haven, Connecticut. Dr. Frampton is also affiliated with Yale New Haven Hospital. The medical group on file is Yale Health. Dmand AI also links Dr. Frampton to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Frampton practices, 3 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Frampton's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Frampton's licenses on file in 2 states: Connecticut and New Hampshire.

CMS data shows 623 Medicare services from Dr. Frampton across 13 procedure codes in 2024, for 256 Medicare patients. Medicare paid $59,614 for them.

CMS counts 256 Medicare patients who saw Dr. Frampton in 2024. The largest group is 65 to 74, with 100 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Frampton's median patient age at 71, with 49% women.

In 2024, Dr. Frampton wrote 2,830 Medicare Part D claims for 452 patients. 84% of them were for generic drugs. CMS names the drug for 2,637 of them, across 30 drugs with 11 or more claims each, at $431,797 in total drug cost. In 2023, CMS named 1,853 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Frampton for performance year 2024, reported as part of a group. Dr. Frampton accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Frampton as offering telehealth. CMS counts 51 procedures of coronary angioplasty and stenting by Dr. Frampton, more than 84% of the clinicians it reports for that procedure.

Dmand AI links 19 papers to Dr. Frampton, published from 2018 to 2025. 2023 was the busiest year, with 7. The most frequent topics are Percutaneous Coronary Intervention, American Heart Association and Coronary Artery Bypass. Dr. Frampton has published most often in Am Heart J. Dr. Frampton's most frequent co-authors are Michael G. Nanna, MD, MHS, Abdulla Al Damluji, MD, MPH and Yasser Jamil, MD.

CMS Open Payments shows 9 general payments to Dr. Frampton from 6 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 79% of the total. Medtronic, Inc. paid the most, $216.

Dr. Frampton graduated from Lake Erie College of Osteopathic Medicine, Erie in 2014.